These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21788704

  • 21. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H, Wenisch JM, Tobudic S, Gualdoni GA, Rödler S, Rasoul-Rockenschaub S, Jaksch P, Redlberger-Fritz M, Popow-Kraupp T, Burgmann H.
    Vaccine; 2011 Sep 16; 29(40):6888-93. PubMed ID: 21803100
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study.
    Choe YJ, Bae GR, Lee DH.
    Vaccine; 2012 Dec 14; 30(52):7439-42. PubMed ID: 23088885
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The adverse events of influenza A (H1N1) vaccination and its risk factors in healthcare personnel in 18 military healthcare units in Korea.
    Hwang SM, Choe KW, Cho SH, Yoon SJ, Park DE, Kang JS, Kim MJ, Chun BC, Lee SM.
    Jpn J Infect Dis; 2011 Dec 14; 64(3):183-9. PubMed ID: 21617300
    [Abstract] [Full Text] [Related]

  • 29. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G.
    Vaccine; 2010 Jan 08; 28(3):849-57. PubMed ID: 19835828
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
    Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH.
    Vaccine; 2012 Mar 09; 30(12):2168-72. PubMed ID: 22265861
    [Abstract] [Full Text] [Related]

  • 32. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults.
    Lopez P, Caicedo Y, Sierra A, Tilman S, Banzhoff A, Clemens R.
    J Infect Dis; 2011 Jun 15; 203(12):1719-28. PubMed ID: 21606530
    [Abstract] [Full Text] [Related]

  • 33. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H, Kaur R, Wang Q, Yang P, Zhang Y, Wang X, Li X, Zhang H, Zhang Z, MacIntyre CR.
    Vaccine; 2011 Feb 11; 29(8):1605-10. PubMed ID: 21211593
    [Abstract] [Full Text] [Related]

  • 34. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.
    MMWR Surveill Summ; 2003 Jan 24; 52(1):1-24. PubMed ID: 12825543
    [Abstract] [Full Text] [Related]

  • 35. Vaccine safety.
    Labadie J.
    Int J Risk Saf Med; 2011 Jan 24; 23(2):113-5. PubMed ID: 21673419
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
    Isai A, Durand J, Le Meur S, Hidalgo-Simon A, Kurz X.
    Vaccine; 2012 Nov 19; 30(49):7123-9. PubMed ID: 23022149
    [Abstract] [Full Text] [Related]

  • 38. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.
    Arch Med Res; 2009 Nov 19; 40(8):693-704. PubMed ID: 20304259
    [Abstract] [Full Text] [Related]

  • 39. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys.
    Walter D, Böhmer MM, Heiden Ma, Reiter S, Krause G, Wichmann O.
    Vaccine; 2011 May 23; 29(23):4008-12. PubMed ID: 21463683
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.